Aditx Therapeutics(ADTX) - Prospectus

As filed with the Securities and Exchange Commission January 18, 2024 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ADITXT, INC. (Exact name of registrant as specified in its charter) 737 N. Fifth Street, Suite 200 Richmond, VA 23219 (650) 870-1200 (Address and telephone number of registrant's principal executive offices) (State or other jurisdiction of incorporation or organization) (P ...